Death from the more serious form of the disease is highest among adults 50 and above, Merck said in a release in December. Even after the FDA approval, the company's single-dose vaccine won't ...

WASHINGTON, D.C. — The Food and Drug Administration (FDA) this week approved a new vaccine, Capvaxive ... Capvaxive, manufactured by Merck Sharp & Dohme LLC, is designed to prevent diseases ...

Sanofi expands its U.S. manufacturing with a $20 billion investment. The FDA approves Merck's cancer drug for rare adrenal ...

Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro.

While the technology is new to flu vaccine production, it has already been used to make vaccines to prevent other infectious diseases. These vaccines have also been approved by the FDA.

The testing that preceded the FDA’s emergency use authorization for Pfizer and the performance of its vaccine since then has shown the drug to be safe and effective, according to Don Yealy ...

“We’re at an early stage in the development of this vaccine, which has never before been given to ... said during the event announcing the FDA-approval of the trial, according to The Washington Post. ...